STREAMEX CORP. Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received
STREAMEX CORP. (STEX) had Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received of $17.00 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Leases › Sales-Type and Direct Financing Leases, Payment to be Received, Fiscal Year Maturity
us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived · last filed 2025-04-15
- 2024-12-31: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $17.00K.
- 2024-09-30: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $44.00K.
- 2024-06-30: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $70.00K.
- 2024-03-31: Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received $95.00K.
| Period end | Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received |
|---|---|
| 2024-12-31 | $17.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $44.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $70.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $95.00K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $121.00K 10-K · filed 2024-04-16 |
| 2023-09-30 | $146.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $173.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $199.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $225.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $117.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |